(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine

Request For Quotation
(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine Suppliers list
Company Name: Lanzhou HuaHao Pharmaceutical Co., Ltd.  Gold
Tel: 18189674620
Email: 761137152@qq.com
Company Name: ChemFuture PharmaTech (Jiangsu) Ltd  
Tel: 5108538618
Email: suger.wang@chemfuture.com
Company Name: Adamas Reagent, Ltd.  
Tel: 400-6009262 15618770481
Email: yhx@titansci.com
Company Name: Shanghai Boc Chemical Co.,Ltd  
Tel: 021-34975603-808 18721111801
Email: sales@bocpharma.com
Company Name: Beijing Lunarsun Pharmaceutical Co.,LTD.  
Tel: 86-10-64911848-8020.8010
Email: sales@lunarsun.com.cn

(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine manufacturers
(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine Basic information
Product Name:(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine
Synonyms:(3S,4S)-N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine hydrochloride (1:2);3-Piperidinamine,N,4-dimethyl-1-(phenylmethyl)-,hydrochloride(1:2),(3S,4S)-;Tofacitinib-2;Tofacitinib impurity 1/(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride;Tofacitinib Impurity 18 DiHCl;Azilsartan medoxomil impurity350;(3S,4S)-1-benzyl-N,4-dimethyl-3-piperidinamine dihydrochloride;Tofacitinib Impurity 108 DiHCl
CAS:1354486-07-9
MF:C14H22N2
MW:218.33788
EINECS:807-114-7
Product Categories:
Mol File:1354486-07-9.mol
(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine Structure
(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine Chemical Properties
storage temp. Inert atmosphere,Room Temperature
AppearanceWhite to off-white Solid
InChIInChI=1/C14H22N2/c1-12-8-9-16(11-14(12)15-2)10-13-6-4-3-5-7-13/h3-7,12,14-15H,8-11H2,1-2H3/t12-,14+/s3
InChIKeyNVKDDQBZODSEIN-DCHPQEBHNA-N
SMILESN1(CC2=CC=CC=C2)CC[C@H](C)[C@H](NC)C1 |&1:10,12,r|
Safety Information
HS Code 2933399990
MSDS Information
(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine Usage And Synthesis
(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine Preparation Products And Raw materials
Tag:(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine(1354486-07-9) Related Product Information
1-Benzyl-n,4-dimethylpiperidin-3-amine dihydrochloride 2,4-Dichloro-7H-pyrrolo2,3-dpyrimidine (3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]- 7H-Pyrrolo[2,3-d]pyrimidine-2,4-diol 1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)- 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide 3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile 4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine 4-chloro-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) Tofacitinib Tofacitinib Impurity 2 N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine